Document is current
Any future updates will be listed below
-
Authors
Kim, Mijin http://orcid.org/0000-0002-7781-9466
Chen, Chen http://orcid.org/0000-0002-4803-0183
Wang, Peng
Mulvey, Joseph J. http://orcid.org/0000-0003-0692-4549
Yang, Yoona
Wun, Christopher
Antman-Passig, Merav
Luo, Hong-Bin
Cho, Sun
Long-Roche, Kara
Ramanathan, Lakshmi V.
Jagota, Anand http://orcid.org/0000-0002-0779-0880
Zheng, Ming http://orcid.org/0000-0002-8058-1348
Wang, YuHuang http://orcid.org/0000-0002-5664-1849
Heller, Daniel A. http://orcid.org/0000-0002-6866-0000
- License Information
-
More Information
Article History
Received: 6 April 2021
Accepted: 10 February 2022
First Online: 17 March 2022
Competing interests
: D.A.H. is a co-founder and officer, with an equity interest, of Goldilocks Therapeutics Inc., Lime Therapeutics Inc. and Resident Diagnostics Inc., and is a member of the scientific advisory board of Concarlo Holdings LLC, Nanorobotics Inc. and Mediphage Bioceuticals Inc. The other authors declare no competing interests.
